사업단 소개
연구사업
동반진단이란
홍보실
연구성과
정보광장
인사말
조직도
CI소개
소개영상
오시는길
사업개요 및 비전
목표 및 단계별 목표
사업추진체계
개념
연구동향
CDX 관련 뉴스
보도자료
사업단 공지사항
포토갤러리
학술대회
논문&특허
관련 보고서
Q&A
관련 사이트
학술정보
TOP
INFORMATION & PAPER
정보광장
정보광장
INFORMATION & Paper
Q&A
관련 사이트
학술정보
CDx
ddPCR
CTC
NGS
Home
>
정보광장
>
CDx
CDx
제목
이름
no.
Year
Title
Author
Journal
9
2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress
H. Wakelee, B. W. Loo, Jr., K. H. Kernstine, J. B. Putnam, Jr., M. J. Edelman, E. E. Vokes, J. H. Schiller, P. Baas, N. Saijo, A. Adjei, G. Goss, H. Choy and D. R. Gandara
Clin Lung Cancer
8
2009
Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity
C. Swanton and R. A. Burrell
Cancer Biol Ther
7
2009
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
C. Schulz, S. Boeck, V. Heinemann and H. J. Stemmler
Anticancer Drugs
6
2009
What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
H. M. Al-Salama, E. C. Johnstone and D. J. Kerr
Discov Med
5
2008
Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer
R. Rosell, C. Manegold, T. Moran, P. Garrido, R. Blanco, P. Lianes, R. Stahel, J. M. Trigo, J. Wei and M. Taron
Clin Lung Cancer
4
2008
Individual chemotherapy of non-small cell lung cancer: from laboratory research to clinical practice]
B. R. Liu, L. Xie and X. P. Qian
Zhonghua Bing Li Xue Za Zhi
3
2008
DxS Ltd
J. Cross
Pharmacogenomics
2
2008
DxS Ltd
J. Cross
Pharmacogenomics
1
2007
Quantitative justification of the change from 10 % to 30 % for human epidermal growth factor receptor 2 scoring in the American society of clinical Oncology/College of American pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue Microarray based assessment of outcome
C. B. Moeder, J. M. Giltnane, M. Harigopal, A. Molinaro, A. Robinson, K. Gelmon, D. Huntsman, R. L. Camp and D. L. Rimm
Journal of Clinical Oncology
First
51
52
Last